Aigh Capital Management LLC Evolus, Inc. Transaction History

Aigh Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $4.75 Million - $6.52 Million	728,528 Added 364.26%	928,528 $6.97 Million
Q3 2022 Nov 10, 2022	BUY	$7.76 - $13.72 $212,686 - $376,037	27,408 Added 15.88%	200,000 $1.61 Million
Q2 2022 Aug 12, 2022	SELL	$10.22 - $13.94 $9.49 Million - $12.9 Million	-928,648 Reduced 84.33%	172,592 $2 Million
Q1 2022 May 12, 2022	BUY	$5.22 - $11.78 $5.75 Million - $13 Million	1,101,240 New	1,101,240 $10.2 Million

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.